Since 1974, the “Special 301 Report” (the Report) provides an annual review of the state of intellectual property protection and enforcement among U.S. trading partners around the world. Amended in 1988 by Congress, the Trade Act is “to provide for… Continue Reading
On April 29, 2020, the United States Trade Representative (USTR) published its annual Special 301 Report. A PDF copy of the report is available here. KEI has compiled copies of the Special 301 Report for every year since its inception… Continue Reading
On Tuesday April 28, 2020, KEI submitted comments to the National Institutes of Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License: AAV Mediated Exendin-4 Gene Transfer to Salivary Glands To Protect Subjects From Diabetes or Obesity” (85… Continue Reading
On Friday, 24 April 2020, Knowledge Ecology International submitted comments on the resolution WHA73: “Covid-19 Response” proposed by the European Union (EU). The original zero draft text and the note verbale proposed by the European Union can be found here.… Continue Reading
Under the notification of laws and regulations obligations of Article 63.2 of the World Trade Organization’s (WTO) TRIPS Agreement, on 23 April 2020, Canada sent a notification (IP/N/1/CAN/30) to the WTO in relation to “Bill C-13 An Act respecting certain… Continue Reading
On March 31st, 2020, the Office of the United States Trade Representative (USTR) published its 2020 National Trade Estimates Report on Foreign Trade Barriers (NTE). As USTR notes, in “accordance with section 181 of the Trade Act of 1974, as… Continue Reading
On Friday April 17, 2020, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License: The Development of Bispecific Antibodies Targeting Glypican 1 (GPC1) for the Treatment of… Continue Reading
On Friday April 17, 2020, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License: Methods and Compositions for Adoptive Cell Therapy” to Lyell Immunopharma, Inc. (85 FR… Continue Reading
On Wednesday, 15 April 2020, the European Union submitted a zero draft of a resolution for the World Health Assembly entitled WHA73: “Covid-19 Response”; this text was accompanied by a note verbale. The note verbale stated the following: We understand… Continue Reading
Brazil-CL-Pandemics-KEI-10April2020 April 10, 2020 Members of the Brazil Congress It is our understanding that some large drug companies have raised objections to a new compulsory licensing authority for Brazil relating to pandemics. I would like to address the several objections… Continue Reading